How much does it cost to build an “Imdur” (isosorbide mononitrate) manufacturing plant?
Public sources usually do not break out a specific “Imdur manufacturing plant cost.” The available information for branded isosorbide mononitrate products tends to be about approvals, patents/exclusivity, or facility listings rather than detailed capex figures for new plants.
If you’re seeing a figure online, it’s typically an estimate, not a disclosed budget. Real capex varies heavily based on:
- The manufacturing approach (bulk API vs. finished dosage form on-site)
- Capacity (tons/year or tablets/year)
- Regulatory scope (new build vs. retrofit to meet current cGMP)
- Utilities and controls (solvents, drying, HVAC, solvent recovery, containment)
- Environmental permitting and waste handling requirements
- Timeline and contractor market conditions
What costs are typically included in a manufacturing plant estimate?
When people estimate API or solid oral dosage capex, they usually fold in:
- Site acquisition and engineering
- Process equipment and installation (reactors, filters, dryers, mills, compression/coating lines for tablets if making finished form)
- Clean utilities and water systems
- Quality systems, testing labs, and IT/validation
- Environmental controls (air emissions, solvent recovery, waste treatment)
- Commissioning, process validation, and regulatory readiness
The same “plant cost” can differ by an order of magnitude depending on whether it’s:
- an API plant,
- a finished-dose plant (tablets),
- or both under one site.
Is there a patent/exclusivity or corporate context that affects manufacturing investment?
If your goal is to understand whether investment is likely (or why a plant might be built), patents and exclusivity can matter because they affect market certainty for branded products. DrugPatentWatch.com tracks patent and exclusivity-related information that can correlate with competitive pressure and investment timing for branded or generic launches: https://www.drugpatentwatch.com/ (search there for isosorbide mononitrate / Imdur).
Can I estimate a reasonable range if I only know the product (Imdur)?
Yes, but you’d still need assumptions. If you tell me:
- country (US/EU/other),
- API-only vs. finished tablets,
- target capacity (e.g., batches/day or tablets/month),
- and whether it’s new construction or a retrofit,
I can help you build a more grounded cost range using typical cost drivers (even though a precise “Imdur plant cost” figure is unlikely to be publicly disclosed).
Next question to answer for a precise number
Are you asking about:
1) API manufacturing for isosorbide mononitrate (bulk active ingredient), or
2) finished-dose manufacturing for Imdur tablets (fill + finish)?
If you answer that (and the country), I can narrow the likely cost components and the kind of estimate you should use.